LncTUG1 ameliorates renal tubular fibrosis in experimental diabetic nephropathy through the miR-145-5p/dual-specificity phosphatase 6 axis

The renal interstitial fibrosis contributes to the progression and deterioration of diabetic nephropathy (DN). Long noncoding RNA taurine-up-regulated gene 1 (TUG1) in kidneys may be down-regulated by hyperglycemia. We aim to explore its role in tubular fibrosis caused by high glucose and the possib...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Renal failure Jg. 45; H. 1; S. 2173950
Hauptverfasser:	Wang, Taoxia, Cui, Shubei, Liu, Xiaoli, Han, Li, Duan, Xiaoting, Feng, Shuning, Zhang, Sen, Li, Guiying
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Taylor & Francis 01.12.2023 Taylor & Francis Ltd Taylor & Francis Group
Schlagworte:	Animals Clinical Study Diabetes Diabetes Mellitus Diabetic Nephropathies - genetics Diabetic Nephropathies - metabolism Diabetic nephropathy Dual Specificity Phosphatase 6 - metabolism DUSP6 Fibrosis Gene silencing Glucose Hyperglycemia Inflammation interstitial fibrosis Kidneys lncTUG1 Mice MicroRNAs - genetics MicroRNAs - metabolism miR-145-5p Nephropathy Phosphatase RNA, Long Noncoding Streptozocin Taurine Diabetic nephropathy interstitial fibrosis lncTUG1 inflammation DUSP6 miR-145-5p
ISSN:	0886-022X, 1525-6049, 1525-6049
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	The renal interstitial fibrosis contributes to the progression and deterioration of diabetic nephropathy (DN). Long noncoding RNA taurine-up-regulated gene 1 (TUG1) in kidneys may be down-regulated by hyperglycemia. We aim to explore its role in tubular fibrosis caused by high glucose and the possible target genes of TUG1. In this study, a streptozocin-induced accelerated DN mouse model and a high glucose-stimulated HK-2 cells model was established to evaluate TUG1 expression. Potential targets of TUG1 were analyzed by online tools and confirmed by luciferase assay. A rescue experiment and gene silencing assay were used to investigate whether TUG1 plays its regulation role via miR-145-5p/dual-specificity phosphatase 6 (DUSP6) in HK2 cells. The effects of TUG1 on inflammation and fibrosis in high glucose treated tubular cells were evaluated by in vitro study, as well as in vivo DN mice model through AAV-TUG1 delivery. Results showed TUG1was downregulated in HK2 cells incubated with high glucose while miR-145-5p was upregulated. Overexpression of TUG1 alleviated renal injury by suppressing inflammation and fibrosis in vivo. Overexpression of TUG1 inhibited HK-2 cell fibrosis and relieved the inflammation. A mechanism study demonstrated that TUG1 directly sponged to miR-145-5p, and DUSP6 was identified as a target downstream of miR-145-5p. In addition, miR-145-5 overexpression and DUSP6 inhibition countervailed the impacts of TUG1. Our findings revealed that TUG1 overexpression alleviates kidney injury in DN mice and decreases the inflammatory response and fibrosis of high glucose-stimulated HK-2 cells via miR-145-5p/DUSP6 axis.
AbstractList	The renal interstitial fibrosis contributes to the progression and deterioration of diabetic nephropathy (DN). Long noncoding RNA taurine-up-regulated gene 1 (TUG1) in kidneys may be down-regulated by hyperglycemia. We aim to explore its role in tubular fibrosis caused by high glucose and the possible target genes of TUG1. In this study, a streptozocin-induced accelerated DN mouse model and a high glucose-stimulated HK-2 cells model was established to evaluate TUG1 expression. Potential targets of TUG1 were analyzed by online tools and confirmed by luciferase assay. A rescue experiment and gene silencing assay were used to investigate whether TUG1 plays its regulation role via miR-145-5p/dual-specificity phosphatase 6 (DUSP6) in HK2 cells. The effects of TUG1 on inflammation and fibrosis in high glucose treated tubular cells were evaluated by in vitro study, as well as in vivo DN mice model through AAV-TUG1 delivery. Results showed TUG1was downregulated in HK2 cells incubated with high glucose while miR-145-5p was upregulated. Overexpression of TUG1 alleviated renal injury by suppressing inflammation and fibrosis in vivo. Overexpression of TUG1 inhibited HK-2 cell fibrosis and relieved the inflammation. A mechanism study demonstrated that TUG1 directly sponged to miR-145-5p, and DUSP6 was identified as a target downstream of miR-145-5p. In addition, miR-145-5 overexpression and DUSP6 inhibition countervailed the impacts of TUG1. Our findings revealed that TUG1 overexpression alleviates kidney injury in DN mice and decreases the inflammatory response and fibrosis of high glucose-stimulated HK-2 cells via miR-145-5p/DUSP6 axis. The renal interstitial fibrosis contributes to the progression and deterioration of diabetic nephropathy (DN). Long noncoding RNA taurine-up-regulated gene 1 (TUG1) in kidneys may be down-regulated by hyperglycemia. We aim to explore its role in tubular fibrosis caused by high glucose and the possible target genes of TUG1. In this study, a streptozocin-induced accelerated DN mouse model and a high glucose-stimulated HK-2 cells model was established to evaluate TUG1 expression. Potential targets of TUG1 were analyzed by online tools and confirmed by luciferase assay. A rescue experiment and gene silencing assay were used to investigate whether TUG1 plays its regulation role via miR-145-5p/dual-specificity phosphatase 6 (DUSP6) in HK2 cells. The effects of TUG1 on inflammation and fibrosis in high glucose treated tubular cells were evaluated by in vitro study, as well as in vivo DN mice model through AAV-TUG1 delivery. Results showed TUG1was downregulated in HK2 cells incubated with high glucose while miR-145-5p was upregulated. Overexpression of TUG1 alleviated renal injury by suppressing inflammation and fibrosis in vivo. Overexpression of TUG1 inhibited HK-2 cell fibrosis and relieved the inflammation. A mechanism study demonstrated that TUG1 directly sponged to miR-145-5p, and DUSP6 was identified as a target downstream of miR-145-5p. In addition, miR-145-5 overexpression and DUSP6 inhibition countervailed the impacts of TUG1. Our findings revealed that TUG1 overexpression alleviates kidney injury in DN mice and decreases the inflammatory response and fibrosis of high glucose-stimulated HK-2 cells via miR-145-5p/DUSP6 axis.The renal interstitial fibrosis contributes to the progression and deterioration of diabetic nephropathy (DN). Long noncoding RNA taurine-up-regulated gene 1 (TUG1) in kidneys may be down-regulated by hyperglycemia. We aim to explore its role in tubular fibrosis caused by high glucose and the possible target genes of TUG1. In this study, a streptozocin-induced accelerated DN mouse model and a high glucose-stimulated HK-2 cells model was established to evaluate TUG1 expression. Potential targets of TUG1 were analyzed by online tools and confirmed by luciferase assay. A rescue experiment and gene silencing assay were used to investigate whether TUG1 plays its regulation role via miR-145-5p/dual-specificity phosphatase 6 (DUSP6) in HK2 cells. The effects of TUG1 on inflammation and fibrosis in high glucose treated tubular cells were evaluated by in vitro study, as well as in vivo DN mice model through AAV-TUG1 delivery. Results showed TUG1was downregulated in HK2 cells incubated with high glucose while miR-145-5p was upregulated. Overexpression of TUG1 alleviated renal injury by suppressing inflammation and fibrosis in vivo. Overexpression of TUG1 inhibited HK-2 cell fibrosis and relieved the inflammation. A mechanism study demonstrated that TUG1 directly sponged to miR-145-5p, and DUSP6 was identified as a target downstream of miR-145-5p. In addition, miR-145-5 overexpression and DUSP6 inhibition countervailed the impacts of TUG1. Our findings revealed that TUG1 overexpression alleviates kidney injury in DN mice and decreases the inflammatory response and fibrosis of high glucose-stimulated HK-2 cells via miR-145-5p/DUSP6 axis. The renal interstitial fibrosis contributes to the progression and deterioration of diabetic nephropathy (DN). Long noncoding RNA taurine-up-regulated gene 1 (TUG1) in kidneys may be down-regulated by hyperglycemia. We aim to explore its role in tubular fibrosis caused by high glucose and the possible target genes of TUG1. In this study, a streptozocin-induced accelerated DN mouse model and a high glucose-stimulated HK-2 cells model was established to evaluate TUG1 expression. Potential targets of TUG1 were analyzed by online tools and confirmed by luciferase assay. A rescue experiment and gene silencing assay were used to investigate whether TUG1 plays its regulation role miR-145-5p/dual-specificity phosphatase 6 (DUSP6) in HK2 cells. The effects of TUG1 on inflammation and fibrosis in high glucose treated tubular cells were evaluated by study, as well as DN mice model through AAV-TUG1 delivery. Results showed TUG1was downregulated in HK2 cells incubated with high glucose while miR-145-5p was upregulated. Overexpression of TUG1 alleviated renal injury by suppressing inflammation and fibrosis . Overexpression of TUG1 inhibited HK-2 cell fibrosis and relieved the inflammation. A mechanism study demonstrated that TUG1 directly sponged to miR-145-5p, and DUSP6 was identified as a target downstream of miR-145-5p. In addition, miR-145-5 overexpression and DUSP6 inhibition countervailed the impacts of TUG1. Our findings revealed that TUG1 overexpression alleviates kidney injury in DN mice and decreases the inflammatory response and fibrosis of high glucose-stimulated HK-2 cells miR-145-5p/DUSP6 axis. The renal interstitial fibrosis contributes to the progression and deterioration of diabetic nephropathy (DN). Long noncoding RNA taurine-up-regulated gene 1 (TUG1) in kidneys may be down-regulated by hyperglycemia. We aim to explore its role in tubular fibrosis caused by high glucose and the possible target genes of TUG1. In this study, a streptozocin-induced accelerated DN mouse model and a high glucose-stimulated HK-2 cells model was established to evaluate TUG1 expression. Potential targets of TUG1 were analyzed by online tools and confirmed by luciferase assay. A rescue experiment and gene silencing assay were used to investigate whether TUG1 plays its regulation role via miR-145-5p/dual-specificity phosphatase 6 (DUSP6) in HK2 cells. The effects of TUG1 on inflammation and fibrosis in high glucose treated tubular cells were evaluated by in vitro study, as well as in vivo DN mice model through AAV-TUG1 delivery. Results showed TUG1was downregulated in HK2 cells incubated with high glucose while miR-145-5p was upregulated. Overexpression of TUG1 alleviated renal injury by suppressing inflammation and fibrosis in vivo. Overexpression of TUG1 inhibited HK-2 cell fibrosis and relieved the inflammation. A mechanism study demonstrated that TUG1 directly sponged to miR-145-5p, and DUSP6 was identified as a target downstream of miR-145-5p. In addition, miR-145-5 overexpression and DUSP6 inhibition countervailed the impacts of TUG1. Our findings revealed that TUG1 overexpression alleviates kidney injury in DN mice and decreases the inflammatory response and fibrosis of high glucose-stimulated HK-2 cells via miR-145-5p/DUSP6 axis.
Author	Zhang, Sen Duan, Xiaoting Cui, Shubei Feng, Shuning Li, Guiying Wang, Taoxia Liu, Xiaoli Han, Li
Author_xml	– sequence: 1 givenname: Taoxia surname: Wang fullname: Wang, Taoxia organization: Department of Nephrology, Affiliated Hospital of Hebei University of Engineering – sequence: 2 givenname: Shubei surname: Cui fullname: Cui, Shubei organization: The First Department of Orthopedics, Handan Central Hospital – sequence: 3 givenname: Xiaoli surname: Liu fullname: Liu, Xiaoli organization: Department of Nephrology, Affiliated Hospital of Hebei University of Engineering – sequence: 4 givenname: Li surname: Han fullname: Han, Li organization: Department of Nephrology, Affiliated Hospital of Hebei University of Engineering – sequence: 5 givenname: Xiaoting surname: Duan fullname: Duan, Xiaoting organization: Department of Nephrology, Affiliated Hospital of Hebei University of Engineering – sequence: 6 givenname: Shuning surname: Feng fullname: Feng, Shuning organization: Department of Nephrology, Affiliated Hospital of Hebei University of Engineering – sequence: 7 givenname: Sen surname: Zhang fullname: Zhang, Sen organization: State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College – sequence: 8 givenname: Guiying orcidid: 0000-0003-4156-784X surname: Li fullname: Li, Guiying organization: Department of Nephrology, Affiliated Hospital of Hebei University of Engineering
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/36794657$$D View this record in MEDLINE/PubMed
BookMark	eNqFkl2L1DAUhousuB_6E5SCN950Nh9N0yKIsui6MCDILngXTtPTaYa2qUmqO3_BX23qzC7uXuhNEpLnfTkn5z1NjkY7YpK8pGRFSUnOSVkWhLFvK0YYXzEqeSXIk-SECiayguTVUXKyMNkCHSen3m8JoaKU7FlyzAtZ5YWQJ8mv9aivby5pCgP2xjoI6FOHI_RpmOu5B5e2pnbWG5-aMcXbCZ0ZcAwRaAzUGIxOR5w6ZycI3S4N8TRvurhjOpivGc1FJqbzZoY-8xNq0xptwi6dOuunDgJ4TIsUbo1_njxtoff44rCfJTefPl5ffM7WXy6vLj6sMy0KFjLBtZRl2eaxR84IrZEzVgKRJUrgpGp4C1ijpEQL2YDEikiWQ12xnLaScn6WXO19GwtbNcV2wO2UBaP-XFi3UeBiWz0qVrayKUnOuNA5b0hFMbpzXcSFEyGj17u91zTXAzY6foyD_oHpw5fRdGpjf6iq4pKQxeDNwcDZ7zP6oAbjNfY9jGhnr5iUMiecyjyirx-hWzu7OKlIlZIKWhJSRerV3xXdl3I38giIPaDjVL3D9h6hRC3RUnfRUku01CFaUff2kS7OEYKxS2Om_6_6_V5txta6AX5a1zcqwK63rnUwauMV_7fFb4gv588
CitedBy_id	crossref_primary_10_1016_j_tem_2025_05_002 crossref_primary_10_1016_j_heliyon_2024_e40891 crossref_primary_10_3389_fphar_2025_1600251 crossref_primary_10_1007_s42000_024_00606_2 crossref_primary_10_1111_1753_0407_13565 crossref_primary_10_1016_j_imbio_2024_152796 crossref_primary_10_1016_j_intimp_2025_114883 crossref_primary_10_1089_dna_2025_0026 crossref_primary_10_1016_j_intimp_2023_111372 crossref_primary_10_1080_0886022X_2025_2521455 crossref_primary_10_1155_ije_9927320 crossref_primary_10_3892_mmr_2023_13048 crossref_primary_10_2147_DMSO_S441082 crossref_primary_10_3389_fendo_2025_1625307 crossref_primary_10_3389_fimmu_2025_1609903 crossref_primary_10_1016_j_sjbs_2024_103976 crossref_primary_10_4254_wjh_v17_i7_106795 crossref_primary_10_1016_j_cophys_2025_100828 crossref_primary_10_2174_0109298673271547231108060805 crossref_primary_10_1002_jbt_23617 crossref_primary_10_1080_0886022X_2025_2480245
Cites_doi	10.1038/nrneph.2016.48 10.1080/13813455.2020.1762657 10.1016/j.intimp.2022.108891 10.1080/09168451.2019.1630251 10.1155/2014/240396 10.1073/pnas.1917663117 10.1038/s41598-018-38250-7 10.1038/cddis.2017.503 10.1093/ndt/gfx336 10.1158/1078-0432.CCR-18-3224 10.3892/mmr.2020.11317 10.1016/j.lfs.2020.118808 10.1111/j.1440-1797.2007.00796.x 10.1186/s40246-017-0113-7 10.1007/s11892-017-0841-z 10.1371/journal.pone.0183488 10.3390/ijms22147575 10.1186/s13148-021-01079-5 10.1172/JCI87927 10.1016/j.biopha.2018.04.191 10.1186/s12935-021-02068-7 10.1016/j.ejphar.2012.05.017 10.5812/ijem.86640 10.3389/fonc.2019.00138 10.1038/nrneph.2017.31 10.1016/j.phymed.2021.153886 10.1016/S0006-291X(02)02084-3 10.1016/j.apsb.2020.10.001 10.7150/ijbs.29063 10.1111/jcmm.14233 10.1016/j.phymed.2018.12.045 10.1074/jbc.M806085200 10.1038/s41401-021-00660-1
ContentType	Journal Article
Copyright	2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 The Author(s)
Copyright_xml	– notice: 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 – notice: 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 The Author(s)
DBID	0YH AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 K9. M0S M1P M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U 7X8 5PM DOA
DOI	10.1080/0886022X.2023.2173950
DatabaseName	Taylor & Francis Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE Publicly Available Content Database
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 0YH name: Taylor & Francis Open Access url: https://www.tandfonline.com sourceTypes: Publisher – sequence: 4 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
DocumentTitleAlternate	T. Wang et al
EISSN	1525-6049
ExternalDocumentID	oai_doaj_org_article_28f7d804235c43d091e3fa3c6fa33057 PMC9937007 36794657 10_1080_0886022X_2023_2173950 2173950
Genre	Research Article Journal Article
GroupedDBID	--- 00X 0YH 123 29P 36B 4.4 53G 5RE 7X7 88E 8FI 8FJ 8G5 ABDBF ABUWG ACGEJ ACGFS ACUHS ADBBV ADCVX ADRBQ ADXPE AENEX AFKRA AFKVX AJWEG ALMA_UNASSIGNED_HOLDINGS AOIJS AQTUD ARJSQ AZQEC BABNJ BCNDV BENPR BLEHA CCPQU CS3 DWQXO EAP EBC EBD EBS EMB EMK EMOBN EPL ESX F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH H13 HMCUK HZ~ M1P M2O M4Z O9- P2P PHGZM PHGZT PIMPY PJZUB PPXIY PROAC PSQYO RPM SV3 TDBHL TFDNU TFL TFW TUS UKHRP V1S ~1N AAYXX AFFHD CITATION .GJ 5VS AALIY AAORF AAPXX ABWCV AFLEI AJVHN AWYRJ BPHCQ BRMBE CAG CGR COF CUY CVF CYYVM CZDIS DRXRE DWTOO ECM EIF EJD HYE JENTW M44 NPM NUSFT PQQKQ QQXMO ZGI ZXP 3V. 7T5 7XB 8FK H94 K9. MBDVC PKEHL PQEST PQUKI Q9U 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c562t-53c7788f40493201be3228a078e7a309d3faebe710c57da7e90724ab9241f7133
IEDL.DBID	0YH
ISICitedReferencesCount	26
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000937431400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0886-022X 1525-6049
IngestDate	Fri Oct 03 12:44:47 EDT 2025 Tue Nov 04 02:06:49 EST 2025 Thu Sep 04 19:56:40 EDT 2025 Tue Oct 07 07:06:33 EDT 2025 Mon Jul 21 05:38:02 EDT 2025 Sat Nov 29 07:58:38 EST 2025 Tue Nov 18 22:18:37 EST 2025 Mon Oct 20 23:47:56 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Diabetic nephropathy interstitial fibrosis lncTUG1 inflammation DUSP6 miR-145-5p
Language	English
License	open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c562t-53c7788f40493201be3228a078e7a309d3faebe710c57da7e90724ab9241f7133
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Supplemental data for this article can be accessed online at https://doi.org/10.1080/0886022X.2023.2173950.
ORCID	0000-0003-4156-784X
OpenAccessLink	https://www.tandfonline.com/doi/abs/10.1080/0886022X.2023.2173950
PMID	36794657
PQID	2871518009
PQPubID	3933335
ParticipantIDs	proquest_miscellaneous_2777403174 pubmed_primary_36794657 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9937007 crossref_primary_10_1080_0886022X_2023_2173950 doaj_primary_oai_doaj_org_article_28f7d804235c43d091e3fa3c6fa33057 crossref_citationtrail_10_1080_0886022X_2023_2173950 proquest_journals_2871518009 informaworld_taylorfrancis_310_1080_0886022X_2023_2173950
PublicationCentury	2000
PublicationDate	2023-Dec
PublicationDateYYYYMMDD	2023-12-01
PublicationDate_xml	– month: 12 year: 2023 text: 2023-Dec
PublicationDecade	2020
PublicationPlace	England
PublicationPlace_xml	– name: England – name: New York
PublicationTitle	Renal failure
PublicationTitleAlternate	Ren Fail
PublicationYear	2023
Publisher	Taylor & Francis Taylor & Francis Ltd Taylor & Francis Group
Publisher_xml	– name: Taylor & Francis – name: Taylor & Francis Ltd – name: Taylor & Francis Group
References	e_1_3_3_30_1 e_1_3_3_18_1 e_1_3_3_17_1 e_1_3_3_19_1 e_1_3_3_14_1 e_1_3_3_13_1 e_1_3_3_16_1 e_1_3_3_35_1 e_1_3_3_15_1 e_1_3_3_10_1 e_1_3_3_33_1 e_1_3_3_34_1 e_1_3_3_12_1 e_1_3_3_31_1 e_1_3_3_11_1 e_1_3_3_32_1 Zhang S (e_1_3_3_24_1) 2013; 2013 e_1_3_3_7_1 e_1_3_3_6_1 e_1_3_3_9_1 e_1_3_3_8_1 e_1_3_3_29_1 e_1_3_3_28_1 e_1_3_3_25_1 e_1_3_3_27_1 e_1_3_3_26_1 e_1_3_3_3_1 e_1_3_3_21_1 e_1_3_3_2_1 e_1_3_3_20_1 e_1_3_3_5_1 e_1_3_3_23_1 e_1_3_3_4_1 e_1_3_3_22_1
References_xml	– ident: e_1_3_3_14_1 doi: 10.1038/nrneph.2016.48 – ident: e_1_3_3_34_1 doi: 10.1080/13813455.2020.1762657 – ident: e_1_3_3_19_1 doi: 10.1016/j.intimp.2022.108891 – ident: e_1_3_3_33_1 doi: 10.1080/09168451.2019.1630251 – ident: e_1_3_3_15_1 doi: 10.1155/2014/240396 – ident: e_1_3_3_27_1 doi: 10.1073/pnas.1917663117 – ident: e_1_3_3_11_1 doi: 10.1038/s41598-018-38250-7 – ident: e_1_3_3_22_1 doi: 10.1038/cddis.2017.503 – volume: 2013 start-page: 819296 year: 2013 ident: e_1_3_3_24_1 article-title: Skimmin, a coumarin from hydrangea paniculata, slows down the progression of membranous glomerulonephritis by anti-Inflammatory effects and inhibiting immune complex deposition publication-title: Evid Based Complement Alternat Med – ident: e_1_3_3_12_1 doi: 10.1093/ndt/gfx336 – ident: e_1_3_3_16_1 doi: 10.1158/1078-0432.CCR-18-3224 – ident: e_1_3_3_18_1 doi: 10.3892/mmr.2020.11317 – ident: e_1_3_3_31_1 doi: 10.1016/j.lfs.2020.118808 – ident: e_1_3_3_26_1 doi: 10.1111/j.1440-1797.2007.00796.x – ident: e_1_3_3_23_1 doi: 10.1186/s40246-017-0113-7 – ident: e_1_3_3_4_1 doi: 10.1007/s11892-017-0841-z – ident: e_1_3_3_32_1 doi: 10.1371/journal.pone.0183488 – ident: e_1_3_3_8_1 doi: 10.3390/ijms22147575 – ident: e_1_3_3_2_1 doi: 10.1186/s13148-021-01079-5 – ident: e_1_3_3_28_1 doi: 10.1172/JCI87927 – ident: e_1_3_3_29_1 doi: 10.1016/j.biopha.2018.04.191 – ident: e_1_3_3_20_1 doi: 10.1186/s12935-021-02068-7 – ident: e_1_3_3_7_1 doi: 10.1016/j.ejphar.2012.05.017 – ident: e_1_3_3_35_1 doi: 10.5812/ijem.86640 – ident: e_1_3_3_21_1 doi: 10.3389/fonc.2019.00138 – ident: e_1_3_3_3_1 doi: 10.1038/nrneph.2017.31 – ident: e_1_3_3_25_1 doi: 10.1016/j.phymed.2021.153886 – ident: e_1_3_3_6_1 doi: 10.1016/S0006-291X(02)02084-3 – ident: e_1_3_3_10_1 doi: 10.1016/j.apsb.2020.10.001 – ident: e_1_3_3_30_1 doi: 10.7150/ijbs.29063 – ident: e_1_3_3_5_1 doi: 10.1111/jcmm.14233 – ident: e_1_3_3_9_1 doi: 10.1016/j.phymed.2018.12.045 – ident: e_1_3_3_17_1 doi: 10.1074/jbc.M806085200 – ident: e_1_3_3_13_1 doi: 10.1038/s41401-021-00660-1
SSID	ssj0015872
Score	2.476973
Snippet	The renal interstitial fibrosis contributes to the progression and deterioration of diabetic nephropathy (DN). Long noncoding RNA taurine-up-regulated gene 1...
SourceID	doaj pubmedcentral proquest pubmed crossref informaworld
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	2173950
SubjectTerms	Animals Clinical Study Diabetes Diabetes Mellitus Diabetic Nephropathies - genetics Diabetic Nephropathies - metabolism Diabetic nephropathy Dual Specificity Phosphatase 6 - metabolism DUSP6 Fibrosis Gene silencing Glucose Hyperglycemia Inflammation interstitial fibrosis Kidneys lncTUG1 Mice MicroRNAs - genetics MicroRNAs - metabolism miR-145-5p Nephropathy Phosphatase RNA, Long Noncoding Streptozocin Taurine
SummonAdditionalLinks	– databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUhhJJLafqRuE2KCr1qY1u2JR_bkKSHNoSSwN6ELMmsIfGatbe0f6G_ujO2vHhDYC-92GBbYHlG1nvSzDxCPhutOaBUy2SZS5ZkoWQ6NIJFcWQiA5TDStOLTYibGzmf57cTqS-MCRvKAw8f7jyWpbASozdSk3AL05vjpeYmgwP4ap9HDqhnJFN-_yCVvWwTDCEMsY3nY-4OVtWWKLsUz2coHD4DRM5zTLqfzEp98f4npUufA6BP4ygnE9PVK_LSI0r6ZejJEdlz9Wvy4offM39D_n6vzd39dUT1o3vAhHwAl3TlsE23LjAKlZbAmZdt1dKqptOS_3RYma0MrV2DegoAF_9QL-0DZ0cfq58sSlKWNueY1MUwcRODjwDb02axbJuF7mCepBnVv6v2Lbm_ury7-Ma8AgMzgIs6lnIjgCOXCfAIDlChcDD-pQZY4YTmYW7BFOAFgFJMKqwWDqh2nOgCSF1UIv19R_brZe1OCBU2y60AthoDQQudkGkBWENbk4Wm0HEWkGS0gDK-PDmqZDyoaKxi6g2n0HDKGy4gs02zZqjPsavBVzTv5mEsr91fAKdT3unULqcLSD51DtX1qyvlIIWi-I4XOB09Sfn_RauQt6YRgPc8IJ82t2Gk4_aNrt1yDc8IgOrwDxZJQI4Hx9v0gmcoFIAvJrZccqub23fqatFXE0eACkDx_f_4Lh_IIXZ1CPc5Jfvdau3OyIH51VXt6mM_RP8Bm5U5ZQ priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwELVgixAXvj8CBRmJq7dJnMTOCVHUwgFWVdVKe4sc2-lGapOwySL4C_xqZhIn7FaIHrhspE0s2fJ4_J49M4-Qd1opDijVMFmkkkWJL5nytWBBGOhAA-UwUvdiE2KxkMtleuIO3FoXVjn6xN5Rm1rjGfkBIvs4AHiTvm--MVSNwttVJ6Fxm-xhpbJoRvYOjxYnp9M9Qix7-SZYShhqGy7HHB6sri1RfilczlFAfA7InKeYfL-1O_VF_K-VMP0bEL0eT7m1QR0_-N-hPST3HTSlHwZbekRu2eoxufvVXb4_Ib--VPrs_FNA1ZW9xMx-QKl0bbFNt8kxnJUWQL7rtmxpWdFt7QA6HPGWmla2QWEGwJ0_qdMIgqelV-UpC6KYxc0BZocxzADFKCYgCbRZ1W2zUh1suDSh6kfZPiXnx0dnHz8zJ-XANACsjsVcCyDbRQSEhAPmyC04EqkAn1ihuJ8aXigwJ4A7OhZGCQucPYxUDuwwKJBHPyOzqq7sC0KFSVIjgPaGwPR8K2ScA2hRRie-zlWYeCQapzDTrs45ym1cZsFYDtXNfIYzn7mZ98h8atYMhT5uanCI9jF9jHW6-z_q9UXmln0WykIYibFHsY64AXBmYaRcJ_ADnlZ4JN22rqzrj2mKQVMl4zd0YH80p8w5njb7Y0seeTu9BpeB90CqsvUGvhGA-cGZi8gjzwfLnUbBE1QcwI6JHZveGebum6pc9WXJEekC4nz57269IvdwEENE0D6ZdeuNfU3u6O9d2a7fuPX7Gwy-SXw priority: 102 providerName: ProQuest
Title	LncTUG1 ameliorates renal tubular fibrosis in experimental diabetic nephropathy through the miR-145-5p/dual-specificity phosphatase 6 axis
URI	https://www.tandfonline.com/doi/abs/10.1080/0886022X.2023.2173950 https://www.ncbi.nlm.nih.gov/pubmed/36794657 https://www.proquest.com/docview/2871518009 https://www.proquest.com/docview/2777403174 https://pubmed.ncbi.nlm.nih.gov/PMC9937007 https://doaj.org/article/28f7d804235c43d091e3fa3c6fa33057
Volume	45
WOSCitedRecordID	wos000937431400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1525-6049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015872 issn: 0886-022X databaseCode: DOA dateStart: 20160101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1525-6049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015872 issn: 0886-022X databaseCode: 7X7 dateStart: 20171101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1525-6049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015872 issn: 0886-022X databaseCode: BENPR dateStart: 20171101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1525-6049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015872 issn: 0886-022X databaseCode: PIMPY dateStart: 20171101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 1525-6049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015872 issn: 0886-022X databaseCode: M2O dateStart: 20171101 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVAWR databaseName: Taylor & Francis Open Access customDbUrl: eissn: 1525-6049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015872 issn: 0886-022X databaseCode: 0YH dateStart: 19870101 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis – providerCode: PRVAWR databaseName: Taylor and Francis Online Journals customDbUrl: eissn: 1525-6049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015872 issn: 0886-022X databaseCode: TFW dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQhhAvfH8ERmUkXt0lcRI7jwytDImWaupE9xQ5jkMjbWnUpAj-Bf5q7hInaifQHuDFUT4c5Zzz-fezz3eEvNNKcUCpGZN5LFkQuZIpVwvm-Z72NFCOTOo22YSYzeRyGc-tN2Ft3SqRQ-ddoIjWVmPnVmnde8QdQ8eIYOhZjjH19xgwNY-RtR_6QE3Qq8u9PBsWEkLZ5m_CKgzr9Jt4_vaaveGpjeJ_I4bpn5DoTYfKnRFq8vA_yPaIPLDwlL7v9OkxuWPKJ-Te1C7APyW_Ppd6cfHRo-raXOHufkCqdGOwTrNN0aWV5kDA13VR06Kku_kDaDfNW2hamgqTMwD2_EltniA4GnpdnDMvCFlYHeMOMYa7QNGTCYgCrVbrulqpBgZdGlH1o6ifkYvJ6eLDGbPpHJgGkNWwkGsBhDsPgJRwwB2pAWMiFWAUIxR344znClQKII8ORaaEAd7uByoFhujlyKWfk4NyXZqXhIosijMB1NcHtucaIcMUgIvKdOTqVPmRQ4L-LybaxjrHlBtXideHRLXtnGA7J7adHTIeqlVdsI_bKpygigwPY6zu9sJ68y2xXT_xZS4yif5HoQ54BgDNgKRcR1CAtRUOiXcVLGnaqZq8y6uS8Fs-4KjXxsQanzpBEhx6wARih7wdboPZwLUgVZr1Fp4RgPvBoIvAIS865R2k4BFmHcAPE3tqvSfm_p2yWLWhyRHtAup89Q8ivSb38bRzGToiB81ma96Qu_p7U9SbUdu7oRRL0ZZyRA5PTmfz81E7mwLl1P8C1-afpvNLOFtMvv4GU4tSzA
linkProvider	Taylor & Francis
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VFAEX3o9AgUWC46bxc9cHhHiVRk2iCLVSOJn1ek0stY6JHaB_gR_Db2TGj5BUiJ564JJIsR3trmdnvm93dj6A51opB1FqzGUSSO76fclVXwtu2Za2NFKOWOpKbEKMx3I6DSZb8Ks9C0Npla1PrBx1PNe0Rr5LyN6zEN4Er_KvnFSjaHe1ldCozeLAnH5Hyla8HLzD9_vCtvfeH77d542qANcY60vuOVog70tcxMYOhr_IoE1LhaHSCOX0g9hJFPYMI6_2RKyEQfpouypComIlROnwfy_BtovGLjuwPRmMJp9W-xaerOSicOpSaq89bc8MUTVvSXJP9rRHguU9ZAJOQIf916JhJRpwpmTq34Dv2fzNtYC4d-N_G8qbcL2B3ux1PVduwZbJbsOVUZNccAd-DjN9ePTBYurEHFPlAkThbGHomXIZUbouS9IIxzEtWJqxdW0EVi9hp5plJifhCcTVp6zRQMJvw07Sj9xyPe7lu3T6jdMJV8rSQhLE8tm8yGeqREDBfKZ-pMVdOLqQkbgHnWyemQfAROwHsUBabyOT7RshvQhBmYq139eRsv0uuK3JhLqp405yIseh1ZZ7bSwtJEsLG0vrQm_1WF4XMjnvgTdkj6ubqQ559cN88SVs3Fpoy0TEknKrPO06MYJPgz11tI8fGElEF4J1aw7LahkqqTVjQuecBuy05hs2jrUI_9huF56tLqNLpH0ulZn5Eu8RyGkwWAm3C_frmbLqheOTogI1TGzMoY1ubl7J0llVdp2QPCLqh_9u1lO4un84GobDwfjgEVyjDtXZTzvQKRdL8xgu629lWiyeNL6DweeLnmO_AUzxpAI
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLbQQBMvjDsZA4zEq7vmaueRWwExqgl1om-WYztrpC2JmhTBX-BXc07iRO0E2gO8tFIdVznO8fH3xcfnI-SVVioElGqYyFPBomQqmJpqzvzA174GymGE7sQm-Hwulsv01GUTNi6tEjl03heK6GI1Tu7a5ENG3DFMjASWnuUEpb8ngKnDFFn7za44Frj0YvZt3EiIRaffhF0Y9hkO8fztb3aWp66K_5Uapn9ColcTKrdWqNnBf7DtLrnj4Cl93fvTPXLDlvfJ_he3Af-A_Dop9eLsg0_Vpb3A0_2AVOnaYp92k2FKK82BgFdN0dCipNv6AbR_zVtoWtoaxRkAe_6kTicIvi29LL4yP4pZXB_jCTGGp0AxkwmIAq1XVVOvVAuLLk2o-lE0D8nZ7P3i7Ufm5ByYBpDVsjjUHAh3HgEpCQF3ZBaCiVCAUSxX4TQ1Ya7ApQDy6JgbxS3w9iBSGTBEP0cu_YjslVVpnxDKTZIaDtQ3gCc-tVzEGQAXZXQy1ZkKEo9Ew1OU2tU6R8mNC-kPJVHdOEscZ-nG2SOTsVvdF_u4rsMbdJHxYqzV3f1Qrc-lm_oyEDk3AvOPYh2FBgCaBUtDncAHRFvukXTbwWTbvarJe10VGV5zA0eDN0oXfBqJJDj2gQmkHnk5NkPYwL0gVdpqA9dwwP0Q0Hnkkce9845WhAmqDuCN8R233jFzt6UsVl1pckS7gDoP_8GkF2T_9N1Mnnyaf35KbmNLnz10RPba9cY-I7f097Zo1s-7if4b-3pNiQ
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LncTUG1+ameliorates+renal+tubular+fibrosis+in+experimental+diabetic+nephropathy+through+the+miR-145-5p%2Fdual-specificity+phosphatase+6+axis&rft.jtitle=Renal+failure&rft.au=Wang%2C+Taoxia&rft.au=Cui%2C+Shubei&rft.au=Liu%2C+Xiaoli&rft.au=Han%2C+Li&rft.date=2023-12-01&rft.pub=Taylor+%26+Francis&rft.issn=0886-022X&rft.eissn=1525-6049&rft.volume=45&rft.issue=1&rft_id=info:doi/10.1080%2F0886022X.2023.2173950&rft_id=info%3Apmid%2F36794657&rft.externalDocID=PMC9937007
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0886-022X&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0886-022X&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0886-022X&client=summon